SDDS 2026: Stanford Drug Discovery Symposium
Welcome to the 10th annual Stanford Drug Discovery Symposium, which will be held at the Arrillaga Alumni Center on the Stanford University campus. This milestone year marks a decade of bringing together all members of the drug discovery community, including researchers, pharmaceutical companies, investment groups, and the broader biomedical community. Over two days, attendees will experience a dynamic program with cutting-edge talks, robust panel discussions, an outstanding poster session showcasing innovative research, and a platform for networking. We look forward to welcoming you to the 10th annual SDDS, and to meaningful conversations and new collaborations that emerge from this year’s event.
— Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute
Registration now open!
Lifetime Achievement Awardees
Michel Sadelain, MD, PhD
Herbert and Florence Irving Professor of Medicine, Columbia University
Carl June, MD
Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine; Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine; Director of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania
Participants
Karen Akinsanya, PhD
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships, Schrödinger
Chris Boshoff, MD, PhD
CSO and President, R&D, Pfizer
Michael Devoy, MB, BS
CMO and EVP of MedAffairs & Pharmacovigilance, Bayer
Thomas Hudson, MD
Venture Partner, Versant Ventures
Roger Kornberg, PhD
Nobel Laureate 2006; Mrs. George A. Winzer Professor of Medicine, Stanford University
Brett Monia, PhD
CEO, Ionis
Michael Quigley, PhD
CSO and Global Head of Research, Sanofi
Randy Schekman, PhD
Nobel Laureate, 2013; Professor of Molecular and Cell Biology, University of California, Berkeley
David Baker, PhD
2024 Nobel Laureate; Henrietta and Aubrey Davis Endowed Prof of Biochemistry, Univ of Washington School of Medicine
James Bradner, MD
Executive Vice President of Research & Development, Amgen
Alistair Henry, PhD
Executive Vice President & CSO, UCB
Joe Jimenez, MBA
Co-Founder and Managing Director, Aditum Bio
Dean Li, MD, PhD
Executive Vice President and President, Merck Research Laboratories
Robert Plenge, MD, PhD
Executive Vice President, Chief Research Officer, Bristol Myers Squibb
John Reed, MD, PhD
Executive Vice President, Innovation Medicine, R&D, Johnson & Johnson
Amit Sinha, MBA
Partner, CIO and Global Head of Life Sciences Investing, Goldman Sachs
Carolyn Bertozzi, PhD
Nobel Laureate 2022
Baker Family Director of Sarafan ChEM-H
Robert Bradway, MBA
Chairman and CEO, Amgen
Sandra Horning, MD
Board Member, Gilead; Board Member, Moderna
Brian Kobilka, MD
Nobel Laureate 2012; Helene Irwin Fagan Chair of Cardiology, Stanford University
Flavius Martin, MD
Executive Vice President, Research, Gilead
Andrew Plump, MD, PhD
President of Research and Development, Takeda
Aviv Regev, PhD, Msc
Head, Executive Vice President, Genentech Research and Early Development
Thomas Südhof, MD
Nobel Laureate 2013; Avram Goldstein Professor and Prof of Neurosurgery, Stanford University
Event Program & Poster
Foundation Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Media Partners
Corporate Poster Session
TBA
Organizers
Amanda Chase, PhD
Associate Director of Strategic Research Development
Stanford Cardiovascular Institute
Kuldev Singh, MD
Professor of Ophthalmology
Stanford University School of Medicine
Sanjay Malhotra, PhD
Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
OHSU
Joseph Wu, MD, PhD
Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine
Mark Mercola, PhD
Professor of Medicine
Stanford University School of Medicine
Francesca Mae G. Tongco, MS-HCA
Project Coordinator
Stanford Cardiovascular Institute
For additional information, please contact Joseph C. Wu, MD, PhD, or Francesca Tongco.